FDA awards humanitarian status to Exalenz's liver diagnostic tool

09/11/2011 | Globes (Israel)

Exalenz Bioscience has secured humanitarian device exemption status from the FDA for its BreathID device in the diagnosis of acute liver failure, shortening its process to FDA approval. The designation comes a week after the company received FDA approval for a clinical study designed to evaluate the efficacy of the device in detecting liver cancer at an early stage.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI